LBP Development in the US Market Report
This report covers:
- A detailed US geographic overview, including breakdowns by company type and headquarters location
- Analysis of US funding trends since 2023, categorized by type, deal value, and therapeutic class
- Comparative analysis of LBPs in clinical trials since 2014, alongside WEDPs
- Comprehensive overview of therapeutic classes for LBPs
You May Also Be Interested In…
Learn More About Microbiome
What is Beacon Microbiome?
- The Most Comprehensive Way to Search the Microbiome Drug Development Landscape: Unique search ontologies based on Microbiome drug and trial characteristics
- Market Leading Approach to Microbiome Preclinical & Clinical Data Curation: Manual curation of key Microbiome research and development data points by Microbiome research scientists
- Seamlessly Integrate Commercial & Scientific Data all in One Place: Search Microbiome company and deal data based on their pipeline and technologies.
- Unrivalled Granularity in Reports & Analysis: Our search ontology and technology indexing enable comprehensive analysis not seen elsewhere.
What is Beacon?
Beacon is the essential intelligence platform for R&D decision-makers working in pharma and biotech, offering unique technology and drug datasets for complex therapeutics and disease areas.
Our market-defining proprietary ontologies, manual data curation, and accurate and comprehensive life science data, provide our customers with unparalleled visibility of the drug, trial and commercial landscape.
This is why 24 of the top 25 pharmaceutical companies trust Beacon to power their critical pipeline, competitive, and commercial decisions.
We’d welcome the opportunity to show you how Beacon can transform your data strategy. Book your personalized demonstration today!
